These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 19162109)
1. A novel vaccine targeting Fusobacterium nucleatum against abscesses and halitosis. Liu PF; Haake SK; Gallo RL; Huang CM Vaccine; 2009 Mar; 27(10):1589-95. PubMed ID: 19162109 [TBL] [Abstract][Full Text] [Related]
2. Halitosis vaccines targeting FomA, a biofilm-bridging protein of fusobacteria nucleatum. Liu PF; Huang IF; Shu CW; Huang CM Curr Mol Med; 2013 Sep; 13(8):1358-67. PubMed ID: 23865430 [TBL] [Abstract][Full Text] [Related]
3. Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis. Liu PF; Shi W; Zhu W; Smith JW; Hsieh SL; Gallo RL; Huang CM Vaccine; 2010 Apr; 28(19):3496-505. PubMed ID: 20189489 [TBL] [Abstract][Full Text] [Related]
4. Effect of IgY on Periodontitis and Halitosis Induced by Wang F; Qiao W; Bao B; Wang S; Regenstein J; Shi Y; Wu W; Ma M J Microbiol Biotechnol; 2019 Feb; 29(2):311-320. PubMed ID: 30609885 [No Abstract] [Full Text] [Related]
5. Vaccination of mice with Porphyromonas gingivalis or Fusobacterium nucleatum modulates the inflammatory response, but fails to prevent experimental periodontitis. Polak D; Wilensky A; Shapira L; Weiss EI; Houri-Haddad Y J Clin Periodontol; 2010 Sep; 37(9):812-7. PubMed ID: 20670341 [TBL] [Abstract][Full Text] [Related]
6. Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model. Gemmell E; Bird PS; Carter CL; Drysdale KE; Seymour GJ Clin Exp Immunol; 2002 May; 128(2):238-44. PubMed ID: 11985513 [TBL] [Abstract][Full Text] [Related]
7. The protective effect of recombinant FomA-expressing Lactobacillus acidophilus against periodontal infection. Ma L; Ding Q; Feng X; Li F Inflammation; 2013 Oct; 36(5):1160-70. PubMed ID: 23644821 [TBL] [Abstract][Full Text] [Related]
8. Cetylpyridinium chloride suppresses gene expression associated with halitosis. Liu J; Ling JQ; Wu CD Arch Oral Biol; 2013 Nov; 58(11):1686-91. PubMed ID: 24112735 [TBL] [Abstract][Full Text] [Related]
9. Interspecies metabolite transfer fuels the methionine metabolism of Hara T; Sakanaka A; Lamont RJ; Amano A; Kuboniwa M mSystems; 2024 Feb; 9(2):e0076423. PubMed ID: 38289043 [TBL] [Abstract][Full Text] [Related]
10. Abscess forming ability of streptococcus milleri group: synergistic effect with Fusobacterium nucleatum. Nagashima H; Takao A; Maeda N Microbiol Immunol; 1999; 43(3):207-16. PubMed ID: 10338189 [TBL] [Abstract][Full Text] [Related]
11. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum. Liu J; Hsieh CL; Gelincik O; Devolder B; Sei S; Zhang S; Lipkin SM; Chang YF J Proteomics; 2019 Mar; 195():125-137. PubMed ID: 30634002 [TBL] [Abstract][Full Text] [Related]
13. Streptococcus spp. and Fusobacterium nucleatum in tongue dorsum biofilm from halitosis patients: a fluorescence in situ hybridization (FISH) and confocal laser scanning microscopy (CLSM) study. Bernardi S; Continenza MA; Al-Ahmad A; Karygianni L; Follo M; Filippi A; Macchiarelli G New Microbiol; 2019 Apr; 42(2):108-113. PubMed ID: 31034083 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of malodorous gas formation by oral bacteria with cetylpyridinium and zinc chloride. Kang JH; Kim DJ; Choi BK; Park JW Arch Oral Biol; 2017 Dec; 84():133-138. PubMed ID: 28987726 [TBL] [Abstract][Full Text] [Related]
15. More Than Just a Periodontal Pathogen -the Research Progress on Chen Y; Huang Z; Tang Z; Huang Y; Huang M; Liu H; Ziebolz D; Schmalz G; Jia B; Zhao J Front Cell Infect Microbiol; 2022; 12():815318. PubMed ID: 35186795 [No Abstract] [Full Text] [Related]
16. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer. Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607 [TBL] [Abstract][Full Text] [Related]
17. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response. Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440 [TBL] [Abstract][Full Text] [Related]
18. Serum neutralizing antibody response and protection against experimentally induced liver abscesses in steers vaccinated with Fusobacterium necrophorum. Saginala S; Nagaraja TG; Tan ZL; Lechtenberg KF; Chengappa MM; Kemp KE; Hine PM Am J Vet Res; 1996 Apr; 57(4):483-8. PubMed ID: 8712511 [TBL] [Abstract][Full Text] [Related]
19. The aetiology and treatment of oral halitosis: an update. Lee PP; Mak WY; Newsome P Hong Kong Med J; 2004 Dec; 10(6):414-8. PubMed ID: 15591601 [TBL] [Abstract][Full Text] [Related]
20. Host modulation of tissue destruction caused by periodontopathogens: effects on a mixed microbial infection composed of Porphyromonas gingivalis and Fusobacterium nucleatum. Ebersole JL; Feuille F; Kesavalu L; Holt SC Microb Pathog; 1997 Jul; 23(1):23-32. PubMed ID: 9250777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]